“June 7, 2004 Intelligence: Late Breaking Lab News”

Business Week Magazine placed Bio-Reference Laboratories, Inc. (BRLI) on its 2004 list of the Top 100 Hot Growth Stocks. BRLI, based in Elmwood Park, New Jersey, was ranked 16th. Business Week announced the list in its June 7, 2004 issue. With steady growth in revenues and net profits in recent years, BRLI’s shares have performed well for investors.


  • LabOne, Inc. of Lenaxa, Kansas has a new Executive Vice President of Healthcare Marketing. Philip A. Spencer was promoted to that position last month. Before coming to LabOne, Spencer held business development positions at both Laboratory Corporation of America and DIANON Systems, Inc.
  • NeoGenomics, Inc., a public cytogenetics company in Fort Myers, Florida, hired Gary LaBarge to be Area Sales Manager for Southeast Florida. LaBarge had formerly been with IMPATH, Inc., with responsibilities for business in Florida.


Think of an in vivo diagnostic instrument that uses RNA to identify disease states in the body—and small enough that one trillion could fit within a water drop! That’s the dream of researchers at the Weizmann Institute of Science in Rehovot, Israel. In a paper published online in the journal Nature on April 28, 2004, Ehud Shapiro, Ph.D. and his colleagues reported on using mRNA to identify the presence of “disease-related genes associated with models of small-cell lung cancer and prostate cancer.” The proof of principle was conducted in vitro, in a test tube. The “hardware” in the computer is an enzyme which cuts DNA strands in a specific way, yielding a “yes” or “no” answer at the end of the reaction. Researchers state that any practical application of this technology will take many years to achieve.


One of the giants of the diagnostic testing industry has died at the age of 104. Arnold O. Beckman, Ph.D., died in his sleep on May 18, 2004. He founded Beckman Instruments in 1935 to sell his first patented invention, a pH meter. He was Chairman Emeritus at the company, now called Beckman Coulter Inc. In 1987, Beckman earned a place in the National Inventors Hall of Fame.


A correction and clarification about ChromaVision Medical Systems, Inc., based in San Juan Capistrano, California. As noted in the last issue of THE DARK REPORT, ChromaVision has raised $26 million in new capital and is refocusing its strategic business plan. It intends to open a laboratory and perform a variety of testing services, including tests using the ChromaVision ACIS® (for auto- mated cellular imaging system). ChromaVision also will continue selling its ACIS instruments to researchers, laboratories and pathology group practices. It has, however, terminated its relationship with US Labs, Inc. As part of its new business strategy, the Company has internalized the remote pathology ACCESS support services previously provided by U.S. Labs.


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.